Related Experiment Video
Updated: Oct 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial
1Department of Internal Medicine, Zuiderziekenhuis, Rotterdam, The Netherlands.
Insights
Antihypertensive treatment with triamterene and hydrochlorothiazide did not prevent renal deterioration in hypertensive patients over five years. Renal function worsened in treated individuals, contrary to the study
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hypertension is a significant risk factor for cardiovascular and renal complications.
- The potential benefits of antihypertensive treatment on renal function in elderly patients remain a subject of investigation.
Purpose of the Study:
- To analyze the effects of antihypertensive treatment on renal function in a cohort of hypertensive patients.
- To evaluate whether combination therapy with triamterene and hydrochlorothiazide can prevent renal deterioration.
Main Methods:
- Prospective, double-blind study involving 840 patients.
- Random assignment to either placebo or active treatment (triamterene and hydrochlorothiazide).
- Five-year follow-up period with monitoring of serum creatinine levels.
Main Results:
- Serum creatinine levels increased significantly in the actively treated group but not in the placebo group.
- Four treated patients and one placebo patient died of renal causes.
- Four treated patients discontinued the study due to a >100% increase in serum creatinine.
Conclusions:
- The combination of triamterene and hydrochlorothiazide did not prevent renal deterioration over five years.
- The incidence of renal complications in elderly hypertensive patients appears to be low.
- Current data do not support the hypothesis that this antihypertensive treatment prevents renal deterioration.
Abstract:
Effects of antihypertensive treatment on renal function were analyzed in data from a prospective, double-blind investigation of 840 patients randomly assigned to placebo or to active treatment with a combination of triamterene and hydrochlorothiazide. Baseline serum creatinine levels were significantly and positively correlated to age, gender (higher in men), systolic blood pressure, and history of cardiovascular complications. During a five-year follow-up period, serum creatinine levels increased significantly in treated patients but not in placebo patients. Five patients died of renal causes (one in the placebo group, four in the treated group), and five patients dropped out of the study because of an increase in serum creatinine of more than 100% (four received active treatment). The incidence of renal complications in the hypertensive elderly is small. The current data do not support the hypothesis that renal deterioration can be prevented by antihypertensive treatment.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
